LBA79 GEMSTONE-303: Prespecified progression-free survival (PFS) and overall survival (OS) final analyses of a phase III study of sugemalimab plus chemotherapy vs placebo plus chemotherapy in treatment-naïve advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma

Xiao Zhang, J. Wang, Guoping Wang, Y. Zhang, Qingxia Fan, Chengping Hu, Meili Sun, Yun Wan, Sanyuan Sun, Jun Wang,

Annals of Oncology · 2023 · 31 citations · 0 references

DOIFull text

Open access

Concepts